Althoughineffective for oral delivery of insulin, ENCP permeability throughthe various intestinal barriers suggests that this NP shows potentialfor local delivery in treatment of, e.g., inflammatory bowel diseaseor colorectal cancer. This evidence concerns the gene INS and colorectal cancer.